Cargando…
P139 Co-morbid insomnia and sleep apnoea (COMISA): Identifying patients that are responsive to continuous positive airway pressure therapy
INTRODUCTION: Co-morbid insomnia and sleep apnoea (COMISA) is a prevalent and debilitating condition that is difficult to treat. COMISA patients have lower average adherence to continuous positive airway pressure (CPAP) therapy compared to patients with sleep apnoea alone. However, a sub-sample of C...
Autores principales: | Sweetman, A, Lack, L, Smith, S, Chai-Coetzer, C, Catcheside, P, Antic, N, Douglas, J, O’Grady, M, Dunn, N, Robinson, J, Paul, D, McEvoy, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109019/ http://dx.doi.org/10.1093/sleepadvances/zpab014.180 |
Ejemplares similares
-
P018 Effect of CBT-I on sleep-wake state discrepancy in individuals with co-morbid insomnia and sleep apnoea: A randomised controlled trial
por: Bensen-Boakes, D, et al.
Publicado: (2022) -
Cognitive behavioural therapy for insomnia reduces sleep apnoea severity: a randomised controlled trial
por: Sweetman, Alexander, et al.
Publicado: (2020) -
Polysomnographic Predictors of Treatment Response to Cognitive Behavioral Therapy for Insomnia in Participants With Co-morbid Insomnia and Sleep Apnea: Secondary Analysis of a Randomized Controlled Trial
por: Sweetman, Alexander, et al.
Publicado: (2021) -
P086 The insomnia severity index is related to the respiratory arousal threshold in people with Co-Morbid Insomnia and Sleep Apnoea (COMISA)
por: Zheng, J, et al.
Publicado: (2022) -
P073 Co-morbid insomnia and obstructive sleep apnoea is associated with all-cause mortality and cardiovascular event risk
por: Lechat, B, et al.
Publicado: (2021)